Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/10/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Rick E. Winningham

Wrong Rick E. Winningham?

Chief Executive Officer

Local Address: South San Francisco, California, United States
Theravance , Inc.
901 Gateway Blvd
S. San Francisco, California 94080
United States

Company Description: Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates. The Company is focused on the discovery,...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • B.S.
    Southern Illinois University
  • M.B.A.
    Texas Christian University
  • B.S. degree
    Southern Illinois University
154 Total References
Web References
Mr. Winningham was ...
www.sec.gov, 12 June 2014 [cached]
Mr. Winningham was previously appointed to the Jazz Pharmaceuticals, Inc. board of directors in May 2010. Messrs. Cozadd and Winningham were elected to our board of directors effective upon the consummation of the Azur Merger.
...
Rick E Winningham, age 54, has served as a member of our board of directors since the Azur Merger and was a director of Jazz Pharmaceuticals, Inc. from 2010 until the Azur Merger. In May 2014, Mr. Winningham was appointed lead independent director of our board of directors. Since 2001, he has served as the Chief Executive Officer and since 2010, as Chairman of the board of directors of Theravance, Inc., a royalty management company. Since May 2014 he has also served as Chief Executive Officer and Chairman of the Board of Directors of Theravance Biopharma, Inc., a biopharmaceutical company. From 1986 to 2001, he held various positions with a pharmaceutical company, Bristol-Myers Squibb and its predecessor Bristol-Myers, including serving as the President of Bristol-Myers Squibb Oncology/Immunology/Oncology Therapeutics Network and, from 2000 to 2001, as its President of Global Marketing. He is the Chairman of the board of directors of the California Healthcare Institute (CHI) and is also a member of the Biotechnology Industry Organization’s Board of Directors, serving on the Health Section Governing Board and Board Standing Committee on Reimbursement. Mr. Winningham holds an M.B.A. from Texas Christian University and a B.S. from Southern Illinois University. Mr. Winningham’s experience in senior management positions in the pharmaceutical industry provides significant industry knowledge and operational and management expertise to our board of directors.
...
Mr. Winningham currently serves as our lead independent director.
Theravance, Inc. : Management Team
investor.theravance.com, 21 Mar 2014 [cached]
Rick E Winningham Chairman and Chief Executive Officer
Rick E Winningham joined Theravance as Chief Executive Officer and a member of the Board of Directors in October 2001, and was appointed Chairman of the Board of Directors in April 2010. Since becoming CEO in late 2001, Theravance has successfully transitioned from a private research-based small molecule discovery company to a public company with a robust portfolio of product candidates.
From 1997 to 2001 he served as President, Bristol-Myers Squibb (BMS) Oncology/Immunology/Oncology Therapeutics Network (OTN) and also as President of Global Marketing from 2000 to 2001. In addition to operating responsibility for U.S. Oncology/Immunology/OTN, Mr. Winningham also had full responsibility for Global Marketing in the Cardiovascular, Infectious Disease, Immunology, Oncology/Metabolics and GU/GI/Neuroscience therapeutic areas. Over a fifteen-year period with BMS and its predecessor, Bristol-Myers, Mr. Winningham held various U.S. and global management positions. During his tenure with BMS, he was associated with the development and commercialization of several major pharmaceutical products, such as Taxol®, Paraplatin®, Zerit®, Videx®, Reyataz®, and Abilify®.
Mr. Winningham holds an M.B.A. from Texas Christian University and a B.S. from Southern Illinois University. He is a member of the Board of Directors of California Healthcare Institute (CHI) and Jazz Pharmaceuticals, Inc. Mr. Winningham is also a member of the External Advisory Board for the College of Business and Administration and Business Hall of Fame at Southern Illinois University.
Board of Directors | CHI
www.chi.org, 25 May 2014 [cached]
Rick E. Winningham
Chairman and CEO
Theravance Biopharma, Inc. ...
www.pharmaadvancement.com, 1 Sept 2014 [cached]
Theravance Biopharma, Inc. announced today that Rick E Winningham, Theravance Biopharma's Chief Executive Officer, is scheduled to present at the following investor conferences in September 2014:
...
Rick E Winningham Chief Executive Officer 650-808-4045 This email address is being protected from spambots.
Jazz Pharmaceuticals Board of Directors
www.jazzpharma.com, 7 June 2014 [cached]
Rick E Winningham Lead Independent Director, Jazz Pharmaceuticals plc
Other People with the name "Winningham":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304